Compounds > 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt
Page last updated: 2024-08-20

1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Nervous System Disorders

1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Nervous System Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kempe, LG; Kobrine, AI1
Bouillet, R1

Other Studies

3 other study(ies) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Nervous System Disorders

ArticleYear
Chymopapain administration procedures modified.
    FDA drug bulletin, 1984, Volume: 14, Issue:2

    Topics: Chymopapain; Drug Labeling; Endopeptidases; Humans; Injections; Intervertebral Disc Displacement; Nervous System Diseases

1984
Diagnosis and management of neurosurgical problems.
    Military medicine, 1976, Volume: 141, Issue:8

    Topics: Chymopapain; Embolization, Therapeutic; Humans; Intervertebral Disc Displacement; Microsurgery; Nervous System Diseases; Neurologic Examination; Pain Management; Seizures; Trigeminal Neuralgia

1976
[Complication of disk nucleolysis with chymopapain].
    Acta orthopaedica Belgica, 1987, Volume: 53, Issue:2

    Topics: Adult; Chymopapain; Drug Hypersensitivity; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Intervertebral Disc; Intervertebral Disc Chemolysis; Male; Middle Aged; Nervous System Diseases; Sciatica; Spinal Diseases; Surveys and Questionnaires

1987